Fidra Energy, a battery storage project developer backed by EIG and the National Wealth Fund, has acquired the 1,025 MW Enderby battery storage project in Leicestershire, U.K., from Innova, an independent developer of renewable energy projects and data centers.

Innova received planning consent for the project in May 2025. The regulator is expected to decide on the project’s application under the scheme in the summer of 2026. Fidra expects to make a final investment decision in 2027, with operations beginning in 2029.

According to Fidra, the project has also been confirmed as eligible for the first long-duration energy storage cap-and-floor scheme application.

The acquisition expands Fidra Energy’s U.K. battery storage pipeline to more than 4 GW. The company is also developing the Thorpe Marsh battery storage project in Yorkshire, where construction has begun. The project has a capacity of 1.4 GW/3.1 GWh.

Morris Van Looy, Chief Growth & Strategy Officer of Fidra Energy, said, “The acquisition of the Enderby battery storage project marks another major milestone in the expansion of our U.K. portfolio and demonstrates our ambition to deliver large-scale battery storage infrastructure at pace to support the U.K. Government’s Clean Power 2030 Action Plan.  We are delighted to be working with Innova, leveraging their experience of working successfully with local stakeholders and communities to develop, build, and operate an exciting project that will help to strengthen the resilience of the U.K.’s electricity system.”

A total of 7.2 GW of energy storage projects were acquired in Q1 2026, a 227% increase compared to the 2.2 GW in Q1 2025, according to Mercom’s recently released Q1 2026 Energy Storage Funding and M&A report. A growing share of acquisitions included standalone battery storage and hybrid solar-plus-storage projects.

In May 2026, GridStor, a developer and operator of utility-scale battery energy storage projects, acquired the 199 MW/796 MWh Birdseye battery storage project in Adams County, Colorado, from Accelergen.